New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 19, 2014
09:27 EDTDOWDow Chemical expects to double EBITDA in agriculture sciences in 5-7 years
Dow Chemical expects to double EBITDA in agricultural sciences in the next 5-7 years to $300M-$400M. The growth will be driven by commercialization of its pipeline, achievement of scale benefits in Seeds and strong agriculture fundamentals. Dow Chemical said all projects are on track for planned start-up, with growth investments achieving a run-rate of $3B in accretive EBITDA. The company said it is on the path to at least $10B in EBITDA in the near term. The company raised its divestiture target by $1.5B-$2B with the total divestiture at $4.5B-$6B. Dow says the Sadara construction is 45% complete and the Olefins construction is 65% complete. The company also said everything is on the table when it comes to shareholder value. Comments taken Down Chemical Strategy Update.
News For DOW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 20, 2015
08:48 EDTDOWNomura taking a bullish long-term view on ethylene
Nomura believes the market is overestimating the potential decline in ethylene/polyethylene margins. The sees the current global tightness as a bullish sign for 2016-2017 and recommends positioning Dow Chemical (DOW) over LyondellBasell (LYB) due to lower reliance on an upside ethylene margin story.
May 15, 2015
11:08 EDTDOWOmega Advisors gives quarterly update on stakes
NEW STAKES: Targa Resources (TRGP), Targa Resources Partners (NGLS), Humana (HUM), Dow Chemical (DOW), and Twenty-First Century Fox (FOXA). INCREASED STAKES: Kinder Morgan (KMI), Chimera Investment Corporation (CIM), AerCap Holdings (AER), Shire (SHPG), and KKR & Co. (KKR). DECREASED STAKES: eBay (EBAY), Altisource Portfolio Solutions (ASPS), Caesars Entertainment (CZR), Navient (NAVI), and TerraForm Power (TERP). LIQUIDATED STAKES: HCA Holdings (HCA), Gilead (GILD), Cabot Oil & Gas (COG), and Apple (AAPL).

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use